27.8 C
Vientiane
Friday, June 27, 2025
spot_img
Home Blog Page 321

KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS

  • THE WORLD’S MOST PRESTIGIOUS OSTEOARTHRITIS SOCIETY (OARSI) HELD FOR THE FIRST TIME IN KOREA  
  • LONG-TERM SAFETY DATA FROM OVER 1 5  YEARS SUPPORT THE SAFETY PROFILE OF TG-C, WITH PRELIMINARY SIGNS OF POTENTIAL EFFICACY BENEFITS

ROCKVILLE, Md., April 28, 2025 /PRNewswire/ — Kolon TissueGene participated in the 2025 Osteoarthritis Research Society International (OARSI) World Congress on Osteoarthritis, which took place in Songdo, South Korea, from April 24-27, 2025. This year marked the first time the globally prestigious osteoarthritis society hosted its annual congress in Korea. During the event, Kolon TissueGene presented new long-term data supporting the safety and efficacy of its investigational therapy, TG-C — the world’s first cell and gene therapy for osteoarthritis — while highlighting its potential for U.S. FDA approval.

On April 25, Kolon TissueGene delivered a presentation titled “TG-C, the First Potential DMOAD*1  Therapy: Intra-Articular Cell-Based Gene Therapy with Long-Term Safety and Insight into Delaying Total Knee Arthroplasty (TKA)”. The presentation focused on TG-C’s long-term safety profile and its potential to delay total knee arthroplasty (TKA), using long-term follow-up data (US LTS) as a basis.

The study included data from 33 subjects who participated in the U.S. Phase 2 trial and 110 subjects from the Phase 3 trial who completed two years of follow-up. The ongoing Phase 3 trial data were analyzed in a blinded manner, including both TG-C and placebo arms, allowing for an objective evaluation of the long-term safety and treatment effects.

Safety Results: No treatment-related tumor cases were reported in TG-C enrolled subjects during nearly 15 years of long-term clinical observation in the United States. Moreover, age-specific cancer incidence among TG-C subjects consistently showed lower rates compared to the general U.S. population, based on SEER (Surveillance, Epidemiology, and End Results) data from the U.S. National Cancer Institute — a compelling indicator of TG-C’s safety.

▶ Age-Specific Cancer Incidence: TG-C U.S. Long-Term Follow-Up (US LTS) vs. U.S. Average (SEER)
▶ Age-Specific Cancer Incidence: TG-C U.S. Long-Term Follow-Up (US LTS) vs. U.S. Average (SEER)

Efficacy Results: Kolon TissueGene also presented data comparing the rate and timing of knee replacement surgery among TG-C–treated subjects versus the broader osteoarthritis population*2 in the U.S. According to the Osteoarthritis Initiative (OAI), which includes 11 years of longitudinal data sponsored by the U.S. National Institutes of Health (NIH), 15.5% of 595 patients meeting TG-C–eligible criteria underwent TKA at a median of 5.1 years after osteoarthritis onset.

In contrast, only 7.0% of TG-C–treated subjects underwent TKA, with the median time to surgery extended to 5.7 years. These findings suggest that TG-C may either replace or significantly delay the need for surgical intervention — a hallmark of a disease-modifying osteoarthritis drug (DMOAD). The data supports TG-C’s potential to slow structural progression of osteoarthritis and offers a meaningful therapeutic alternative.

Executive Commentary: Dr. Moon Jong Noh, Co-CEO of Kolon TissueGene, stated, “We are honored to share meaningful TG-C data at the first-ever OARSI congress held in Korea. This opportunity reinforces our optimism for FDA approval and recognition of TG-C as the world’s first DMOAD therapy.” Co-CEO Seng Ho Jeon, who joined the company in March, added, “The scientific data presented strongly supports the safety and efficacy of TG-C. We are pursuing parallel strategies for both regulatory approval and commercialization to establish TG-C as a global blockbuster treatment.”

About OARSI: Headquartered in New Jersey, USA, the Osteoarthritis Research Society International (OARSI) is the world’s leading organization for scientists and healthcare professionals working in the field of osteoarthritis prevention and treatment. Each year, the society holds its global congress in major cities worldwide, drawing over 1,500 experts from more than 50 countries, including clinical researchers, orthopedic specialists, radiologists, and physical therapists.

About TG-C: TG-C is the world’s first cell and gene therapy developed for knee osteoarthritis and is classified as a first-in-class investigational drug. It is currently undergoing follow-up in a U.S. Phase 3 trial following completion of dosing. As of 2024, the osteoarthritis market in the seven major countries (U.S., France, Germany, Italy, Spain, U.K., and Japan) is estimated at KRW 3.8 trillion, with a projected compound annual growth rate of 5.3%, reaching KRW 5.5 trillion by 2031. The global market is expected to exceed KRW 12 trillion. Currently dominated by low-cost analgesics, the introduction of effective disease-modifying therapies like TG-C could significantly expand market potential. (Source: GlobalData, Osteoarthritis: Epidemiology Forecast to 2031, June 17, 2022)

(*1) Disease-Modifying Osteoarthritis Drug
(*2) Data from the Osteoarthritis Initiative (OAI), a large-scale, public, long-term follow-up study sponsored by the U.S. National Institutes of Health (NIH).

▶ Dr. David Hunter presenting on TG-C at the OARSI World Congress
▶ Dr. David Hunter presenting on TG-C at the OARSI World Congress

 

 

Nisun International to Report Full-Year 2024 Financial Results and Host Earnings Conference Call on Tuesday, April 29th, 2025

SHANGHAI, April 28, 2025 /PRNewswire/ — Nisun International Enterprise Development Group Co., Ltd (“Nisun International” or the “Company”) (Nasdaq: NISN), a technology- and industry-driven integrated supply chain solutions provider, today announced that it will report its audited financial results for the full year ended December 31, 2024, after the close of the market on Tuesday, April 29th, 2025, at 4:15 p.m. New York Time.

The Company will host a conference call to discuss the financial results and provide an update on recent business developments.

Conference Call Details:

  • Date: Tuesday, April 29, 2025
  • Time: 4:30 p.m. New York Time (4:30 a.m. Wednesday, April 30th, 2025, Beijing Time)
  • Dial-in Numbers:
    • US (Local): +1 323-794-2551
    • US/Canada (Toll-Free): +1 800-239-9838
    • Canada (Local): +1 647 794 4605
    • China (National): +86 400 613 7997

A replay of the conference call will be available for 7 days, beginning Wednesday, April 30, 2025, via the same webcast link.

About Nisun International Enterprise Development Group Co., Ltd

Nisun International Enterprise Development Group Co., Ltd (NASDAQ: NISN) is a technology-driven, integrated supply chain solutions provider focused on transforming the corporate finance industry. Leveraging its industry experience, Nisun International is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, Nisun International provides users with professional solutions for technology supply chain management, technology asset routing, and digital transformation of tech and finance institutions, enabling the industry to strengthen and grow. At the same time, Nisun International continues to deepen the field of industry segmentation through industrial and financial integration. Focusing on industry-finance linkages, Nisun International aims to serve the upstream and downstream of the industrial supply chain while also assisting with supply-side sub-sector reform. For more information, please visit http://ir.nisun-international.com/

Cautionary Note Regarding Forward-Looking Statements

This press release contains information about Nisun International ‘s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Nisun encourages you to review other factors that may affect its future results in Nisun’s registration statement and in its other filings with the Securities and Exchange Commission. Nisun assumes no obligation to update or revise its forward-looking statements as a result of new information, future events or otherwise, except as expressly required by applicable law.

 

BCI debuts Solartech Indonesia 2025, Showcasing the Image of a Professional Solar cell Manufacturer

JAKARTA, Indonesia, April 28, 2025 /PRNewswire/ — From April 23 to 25, PT BINTAN CELLULAR INDONESIA (BCI), a leading solar cell manufacturer in Indonesia, took center stage at Solartech Indonesia 2025—the region’s largest solar energy exhibition held at Jakarta International Expo. Showcasing its cutting-edge technology, BCI attracted over 25,000 industry professionals and key stakeholders, solidifying its reputation as a pioneer in Southeast Asia’s renewable energy landscape.

1. Exhibition Scale & Impact

This year’s show kicked off at the Jakarta Convention and Exhibition Center, covering 30,000 square meters of exhibition space and attracting more than 800 exhibitors from 25 countries and over 25,000 professional visitors. BCI became one of the most popular Asian faces on the show floor by virtue of its differentiated technological routes.

2. BCI ‘s Technological Breakthrough

In the field of production and R&D, we focus on the innovation and expansion of photovoltaic cells, with continuous innovation capability and mature production system, which can realize the R&D and production of 210, 183.75 full series of photovoltaic cells, and we are committed to meeting the diversified needs of the market with a diversified product layout, and we are injecting impetus for the development of the photovoltaic industry through continuous optimization of process and technology iteration, showing our comprehensive strength and comprehensive layout in the field of photovoltaic cells. BCI is committed to meeting the diversified needs of the market with a diversified product layout.

It is noteworthy that BCI has revealed that its new generation of technology routes will be released soon.

3.Highlighted advantages of the industrial chain and significant synergies 

BCI has successfully built up a complete industrial system covering R&D, production and market expansion. Relying on more than 100 core patented technologies from its parent company, BCI’s annual production capacity has exceeded 7GW, and its products have reached an industry-leading level in terms of conversion efficiency and cost control. Meanwhile, BCI has launched two innovative energy storage systems for Southeast Asia, which is characterized by abundant light resources: the 6.2kW household storage off-grid system and the 215KWH small-scale industrial and commercial “light storage and charging integration” system. These two systems have received widespread attention from dealers and customers due to their outstanding advantages of high economic efficiency, fast payback, reliable quality and intelligent interconnection.

4. BCI ‘s Vision for Indonesia ‘s Solar Future

“Indonesia’s solar potential is immense, and BCI is committed to driving innovation that makes clean energy accessible and affordable,” said BCI’s CEO. “By combining local manufacturing expertise with global R&D capabilities, we aim to position Indonesia as a key player in the global solar supply chain.”

As Solartech Indonesia 2025 concluded, BCI reaffirmed its mission to lead Southeast Asia’s energy transition through technological excellence and sustainable partnerships.

BCI debuts Solartech Indonesia 2025, Showcasing the Image of a Professional Solar cell Manufacturer

JAKARTA, Indonesia, April 28, 2025 /PRNewswire/ — From April 23 to 25, PT BINTAN CELLULAR INDONESIA (BCI), a leading solar cell manufacturer in Indonesia, took center stage at Solartech Indonesia 2025—the region’s largest solar energy exhibition held at Jakarta International Expo. Showcasing its cutting-edge technology, BCI attracted over 25,000 industry professionals and key stakeholders, solidifying its reputation as a pioneer in Southeast Asia’s renewable energy landscape.


1. Exhibition Scale & Impact

This year’s show kicked off at the Jakarta Convention and Exhibition Center, covering 30,000 square meters of exhibition space and attracting more than 800 exhibitors from 25 countries and over 25,000 professional visitors. BCI became one of the most popular Asian faces on the show floor by virtue of its differentiated technological routes.

2. BCI‘s Technological Breakthrough

In the field of production and R&D, we focus on the innovation and expansion of photovoltaic cells, with continuous innovation capability and mature production system, which can realize the R&D and production of 210, 183.75 full series of photovoltaic cells, and we are committed to meeting the diversified needs of the market with a diversified product layout, and we are injecting impetus for the development of the photovoltaic industry through continuous optimization of process and technology iteration, showing our comprehensive strength and comprehensive layout in the field of photovoltaic cells. BCI is committed to meeting the diversified needs of the market with a diversified product layout.

It is noteworthy that BCI has revealed that its new generation of technology routes will be released soon.

3.Highlighted advantages of the industrial chain and significant synergies 

BCI has successfully built up a complete industrial system covering R&D, production and market expansion. Relying on more than 100 core patented technologies from its parent company, BCI’s annual production capacity has exceeded 7GW, and its products have reached an industry-leading level in terms of conversion efficiency and cost control. Meanwhile, BCI has launched two innovative energy storage systems for Southeast Asia, which is characterized by abundant light resources: the 6.2kW household storage off-grid system and the 215KWH small-scale industrial and commercial “light storage and charging integration” system. These two systems have received widespread attention from dealers and customers due to their outstanding advantages of high economic efficiency, fast payback, reliable quality and intelligent interconnection.

4. BCI‘s Vision for Indonesia‘s Solar Future

Indonesia’s solar potential is immense, and BCI is committed to driving innovation that makes clean energy accessible and affordable,” said BCI’s CEO. “By combining local manufacturing expertise with global R&D capabilities, we aim to position Indonesia as a key player in the global solar supply chain.”

As Solartech Indonesia 2025 concluded, BCI reaffirmed its mission to lead Southeast Asia’s energy transition through technological excellence and sustainable partnerships.

Complete Genomics, Velsera partner to integrate sequencing and analysis platforms

CHICAGO, April 28, 2025 /PRNewswire/ — Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data analysis solution. 

The partnership, announced this week at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, will accelerate and streamline the path from sample to clinical report, enabling faster, more accurate, and cost-efficient genetic testing for clinical oncology labs, assay developers for ultimately better patient care.

“This partnership enables clinical laboratories and assay developers to accelerate the path from raw sequencing data to actionable clinical insights,” said Lisa Weingartner, Head of Global Partnerships at Velsera. “By integrating variant interpretation, tertiary analysis, reporting, and decision support into a unified workflow, we are helping labs expand genomic testing with greater accuracy, consistency, and confidence.”

Velsera will offer plug-in workflows within the CGW to support streamlined implementation of standard off-the-shelf assays using post-secondary analysis and secondary analysis integration models. Complete Genomics will contribute a range of low- to high-throughput DNBSEQ genetic sequencing solutions lab automation platforms.

“Through our partnership with Velsera, Complete Genomics is expanding our ability to serve clinical laboratories with a truly end-to-end solution from sample to insight,” said Rob Tarbox, vice president of product and marketing at Complete Genomics. “By combining our advanced sequencing and lab automation with Velsera’s Clinical Genomics Workspace for data analysis and reporting, we’re empowering labs to deliver high-quality, actionable results with greater efficiency and confidence.”

About Complete Genomics

Complete Genomics is a pioneering life sciences company that provides novel, end to end DNA sequencing solutions. It has been at the forefront of high throughput cost-effective sequencing technology development since its inception in 2005. Our products have powered more than 10,900 publications across a wide array of applications. To learn more, visit www.completegenomics.com.

* For Research Use Only. Not for use in diagnostic procedures.

About Velsera

Velsera’s mission is to be the discovery, evidence generation, and clinical delivery platform for precision medicine. We help experts in clinical diagnostics and life sciences make better decisions about providing the right therapy to the right patients at the right time. Velsera was founded in 2023 as a result of the merger of Seven Bridges, PierianDx and UgenTec and operates in the US, Europe and Asia.

 

 

ESR to Launch the World’s First Magnetic Wireless Mouse on Kickstarter April 28

WILMINGTON, Del., April 28, 2025 /PRNewswire/ — ESR, the world’s No.1 brand in MagSafe accessories, launches its latest breakthrough—the ESR MagMouse Wireless Mouse—on Kickstarter starting April 28, 2025. MagMouse was unveiled at CES 2025, instantly capturing widespread attention and praise for its innovative design and outstanding performance.

Designed with modern mobility in mind, the MagMouse is the world’s first magnetically attachable mouse with a built-in fast-charging cable, engineered for people who work, study, and create on the go. By combining portability, functionality, and an innovative design, MagMouse embodies ESR’s mission “Tech Made Easier,” reimagining what a wireless mouse can be and how it can simplify working on the go.

Snap, Go and Charge Anywhere
Snap, Go and Charge Anywhere

Magnetic Portability for On-the-Go Users

The MagMouse redefines convenience by allowing users to simply attach the mouse to their laptop or tablet using a magnetic base with a reusable 3M adhesive. With a magnetic strength of 600 grams, the base firmly holds the lightweight 75-gram mouse in place, enabling hands-free carry. The retractable magnetic pins on the positioning base and the magnetic rings seamlessly lock into the embedded magnetic circle on the bottom of the mouse, ensuring double stability and impact resistance to prevent accidental detachment. It was designed for situations such as frequent meetings, coffee breaks, or classroom hops—short yet sometimes frequent moves where you often have a coffee or phone in one hand and a laptop and mouse in the other. In situations like these, MagMouse magnetically attaches to your laptop, freeing your hands.

Effortless Charging, Unmatched Convenience

In addition to its game-changing portability, the MagMouse features a built-in charging cable that stows away invisibly when not in use, meaning users never need to carry a separate cable. When it’s time to recharge, simply plug the built-in USB-C cable into your laptop for easy, on-the-go power—anytime, anywhere. Its 500 mAh rechargeable battery supports lightning-fast charging: just one minute provides up to four hours of use, while a full charge takes only 45 minutes and lasts for 160 hours.

Smarter Scroll and Feature-Rich

A four-way scroll wheel lets you move smoothly up and down through websites or documents, and tilt left or right to effortlessly navigate spreadsheets, timelines, or wide images – no more dragging or awkward side-scrolling. Its easy-to-grip design, back and forward navigation buttons, support prolonged use with ease. The MagMouse also delivers a premium user experience with:

  • Dual connectivity via 2.4 GHz and Bluetooth 5.0
  • Six adjustable DPI levels up to 4800
  • Compatibility with major operating systems including Windows, macOS, iPadOS, Android, Linux, and iOS.

Building on Success, Powered by Innovation

The Kickstarter campaign builds on the success of ESR’s previous crowdfunding triumph, the Geo Wallet with Find My, which launched on Kickstarter in 2024. That product attracted over 4,600 backers and earned the iF Design Award 2025 and the Best of Kickstarter title for its sleek design and powerful anti-theft capabilities.

“At ESR, we’re driven by a simple belief: the best tech doesn’t just do more—it makes your life easier,” said Tim Wu, CEO of ESR. “MagMouse is the result of listening to how people work and create on the move. By rethinking the form and function of the wireless mouse, we’ve built a solution that travels with you, powers up fast, and stays out of your way when you need your hands free. We’re excited to bring this innovation to life with our Kickstarter community.”

With MagMouse, ESR continues to expand the boundaries of user-centric tech design by leveraging its magnetic expertise to solve everyday problems. Whether commuting across town or moving between classrooms, the MagMouse is built to move effortlessly and reliably with any lifestyle.

The MagMouse officially launches on Kickstarter on April 28, with early backers gaining access to a Super Early Bird price of $24, which is a 32% discount on its original price of $36.

About ESR: Trusted for 16 Years

Founded in 2009, and now with a user base of over 123 million people worldwide, ESR is a leading brand of mobile accessories and the No. 1 brand for MagSafe accessories. From cases that do more than protect to wireless chargers that reimagine what’s possible with MagSafe, we’re on a mission to make tech easier to use. To stay updated on the latest news and product launches around ESR, please visit www.esrtech.com or follow ESR’s social media on X, Instagram, and Facebook.

 

MEXC Announces the Listing of MilkyWay (MILK) with 448,000 MILK and 50,000 USDT Prize Pool

VICTORIA, Seychelles, April 28, 2025 /PRNewswire/ — MEXC, a leading global cryptocurrency exchange, announces the upcoming listing of MilkyWay (MILK) on April 29, 2025 (UTC). To celebrate this significant addition to the exchange, MEXC is launching a special event with a prize pool of 448,000 MILK and 50,000 USDT for both new and existing users.

MEXC Announces the Listing of MilkyWay (MILK) with 448,000 MILK and 50,000 USDT Prize Pool
MEXC Announces the Listing of MilkyWay (MILK) with 448,000 MILK and 50,000 USDT Prize Pool

MilkyWay is a next-generation restaking protocol addressing security fragmentation across modular blockchains. As a liquid staking solution within the Celestia ecosystem and the leading restake protocol under Initia, it allows staked assets to secure multiple chains while improving capital efficiency through liquid staking (milkTIA) and AVS integration. It is currently integrated with over 10 DeFi protocols, including Osmosis, Levana, and Mars, offering users services such as trading, leverage, lending, and yield farming.MilkyWay’s TVL currently reaches $190 million.

$MILK is the governance token of the MilkyWay ecosystem. Holders can stake to support network security, vote on proposals, and earn rewards through staking, liquidity incentives, and ecosystem growth. 10% of the total supply is airdropped to Celestia TIA stakers as a tribute to early supporters.

To celebrate the listing, MEXC will launch an Airdrop+ event from April 28, 2025, 13:00 to May 8, 2025, 10:00 (UTC). The event includes the following benefits:

Benefit 1: Deposit and share 336,000 MILK (New user exclusive)
Benefit 2: Futures Challenge — Trade to share 50,000 USDT in Futures bonus (For all users)
Benefit 3: Invite new users and share 112,000 MILK (For all users)

The listing of MilkyWay (MILK) is just the latest example of MEXC’s dedication to bringing the most innovative and timely assets to its platform. According to the latest TokenInsight report, from November 1, 2024, to February 15, 2025, MEXC led the industry with an impressive 461 spot listings. During each bi-weekly period, MEXC maintained a high listing frequency, consistently ranking among the top six exchanges and demonstrating its ability to capture market trends quickly. To date, MEXC has listed more than 3,000 digital assets. MEXC will continue to maintain its industry-leading listing efficiency, innovate, and expand its offerings, ensuring users have access to the best opportunities in the ever-evolving crypto landscape.

For full event details and participation rules, visit here.

About MEXC

Founded in 2018, MEXC is committed to being “Your Easiest Way to Crypto.” Serving over 36 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, everyday airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding.

MEXC Official Website  X Telegram |How to Sign Up on MEXC

Risk Disclaimer:

The information provided in this article regarding cryptocurrencies does not constitute investment advice. Given the highly volatile nature of the cryptocurrency market, investors are encouraged to carefully assess market fluctuations, the fundamentals of projects, and potential financial risks before making any trading decisions.

Silverfort Expands its Non-Human Identity (NHI) Security Offering to the Cloud for End-to-End Identity Security

Only Silverfort secures all human and non-human identities across all environments in a single platform  from workforce identities to workload identities, service accounts, access keys and tokens, whether on-prem, cloud-native or hybrid

Stop lateral movement, discover & visualize connections between human and NHIs across hybrid environments, enforce service accounts protection, and get actionable remediation recommendations

BOSTON, April 28, 2025 /PRNewswire/ — Silverfort, the leading identity security company, today introduced expanded protection of its non-human identity (NHI) security product to include cloud-based identities, covering NHIs in cloud identity providers, cloud infrastructure, and SaaS applications. With this announcement, Silverfort successfully integrated capabilities inherited from the Rezonate acquisition in November 2024. Organizations can now turn to Silverfort to meet every identity security need from human to non-human across their hybrid environments—from cloud to on-prem.

NHIs are mission critical for business, but secured as an afterthought
NHIs—service accounts, API keys, tokens, service principals, IAM roles, certificates, secrets, and more—are the connective tissue in an organization’s network. They are the backbone of a modern organization’s processes, allowing applications to interact with one another, yet their security remains fragmented and misaligned with their critical role. Created to “set and forget,” NHIs are difficult to track, and securing them is often split into minor features across different platforms, creating security gaps and blind spots.

56% percent of organizations unknowingly sync their service accounts to their SaaS directory, increasing the attack surface by creating a multitude of dormant accounts in cloud identity management platforms. Excessive privileges, stale credentials, and lack of clear ownership make them prime targets for attackers and create compliance gaps. It’s estimated that NHIs outnumber human identities by at least 50 to one, and that gap is widening fast, fueled by the explosive growth of Generative AI and autonomous agents. Human identities often serve as the gateway to NHIs, which are a core component in an attacker’s kill chain.

“Emerging NHI-focused vendors attempt to address the problem with bespoke, point solutions that tackle a small fraction of the issue. But attackers don’t think in fragments. They exploit the entire attack surface, searching for any weakness that grants them access. Point solutions fail to provide full visibility into human and non-human identities across resources, leaving organizations with blind spots and unprotected gaps,” said Roy Akerman, VP of Identity Security Strategy, Silverfort.

“To effectively manage NHIs, organizations need cross-platform, hybrid support, and a platform that can do more than secure NHIs. Yes, NHIs are a challenge, but they are only one element in the broader identity security challenge. That’s why at Silverfort, we’ve integrated our NHI security offering into our broader platform, giving our customers visibility into and control over the entire attack surface—not just the NHI components.”

Introducing the Only Identity Security Platform to Cover Both Humans and NHIs Across Both Cloud and On-Prem
For the last few years, Silverfort has been on a mission to solve the unmet need for a unified platform that could secure all identities across all environments. As part of this vision, the company acquired Rezonate in late 2024, an innovative cloud identity security company with offerings that span identity threat detection and response (ITDR), identity security posture management (ISPM), Identity Governance and Administration (IGA) and NHI security. By expanding its ability to secure cloud-based NHIs, Silverfort became the first company to provide seamless, scalable security for all human and non-human identities, both on-prem and in the cloud, from a single platform. 

With these capabilities, Silverfort has the power to map NHI effective privileges, activities, risk indicators and usage patterns. Using behavioral insights, Silverfort automatically generates policies that can halt lateral movement, blocking unauthorized access the moment an NHI deviates from its normal activity. Unlike traditional methods, Silverfort automatically determines the human ownership of each NHI, which makes it much easier to enforce accountability and streamline remediation. For faster deployments and easy ongoing maintenance, Silverfort integrates with existing identity infrastructure, from Active Directory to Entra ID, from AWS to Azure, from GitHub to Snowflake, providing cross-platform protection that spans hybrid environments, leaving no identity unprotected.

Key benefits include:

  • Unified coverage for human identities and NHIs, both on-prem and in the cloud: Integrate intelligence from cloud and on-prem into a unified interface to secure all human and non-human identities, eliminating silos and enabling streamlined security operations.
  • Complete discovery and ownership mapping: Discover and classify non-human identities— from on–prem Active Directory service accounts, to NHIs in cloud identity providers, cloud infrastructure, and SaaS applications. Conduct ownership mapping, view effective privileges, and eliminate redundant or excessive permissions.
  • Proactive NHI security posture management: Use cross-platform context to analyze activity, risk indicators, ownership, misconfigurations, and usage patterns. Enhance overall NHI security posture with actionable insights into dormant, exposed, unrotated and other at-risk NHIs and remediation recommendations.
  • Prevention of lateral movement and real-time protection of Service Accounts: Real-time enforcement of ‘Virtual Fencing’ for all Active Directory service accounts, to block any use of the account outside of its intended purpose, making lateral movement impossible. Automate protection of large numbers of service accounts with Silverfort’s Smart Policy, scaling and streamlining enforcement across large, complex environments.

The Silverfort Identity Security Platform
With identity security as Silverfort’s sole focus and mission, the company pioneered a way to deliver end-to-end identity security—securing every dimension of identity via its patented technology, Runtime Access Protection (RAP). RAP natively integrates into an enterprise’s identity infrastructure to extend protection to previously “unprotectable” assets like non-human identities (NHIs), legacy systems, command line tools, IT/OT infrastructure and more. The result is identity security with end-to-end visibility and active protection—with minimal disruption to users or administrators.

More than 1,000 enterprises including UPS, Airbus, and Kayak trust Silverfort to protect their identities. This involves analyzing and verifying over 10 billion authentications daily and deploying 17x faster than traditional identity security solutions for a better time to value. In the last year, Silverfort raised $116M in Series D funding, introduced Privileged Access Security (PAS), and launched its Identity-First Incident Response solution. Additionally, Fast Company named Silverfort a 2025 Most Innovative Company, listed in the security category alongside others who are pushing the boundaries of what’s possible to create a more secure world.

Silverfort will be at the RSAC™ Conference at booth number #3404. Learn more at RSA, book a demo to see Silverfort NHI Security in action, or visit Silverfort NHI Security for more details.

About Silverfort
Fueled by a belief that identity professionals deserve better, we found a way to break down the silos of identity security—eliminating the gaps and blind spots left behind by a patchwork of point solutions. The Silverfort Identity Security Platform is the first to deliver end-to-end identity security, protecting every identity in the cloud, on-prem, humans, machines, and everything in between. Our patented technology—Runtime Access Protection (RAP)—natively integrates with the entire IAM infrastructure, giving businesses visibility into all identities, analyzing every access, and extending active protection to resources that could not be protected previously—including NHIs, legacy systems, command line tools, and IT/OT infrastructure. It is easy to deploy and use, and doesn’t disrupt business operations, resulting in better security outcomes with less work. Silverfort is the identity security platform that both identity and security professionals deserve, earning the trust of more than 1,000 leading organizations, including several Fortune 50 companies. Learn more at silverfort.com.

Silverfort, The Leader in Identity Security.
Silverfort, The Leader in Identity Security.

Video – https://mma.prnewswire.com/media/2673796/Silverfort_Expands_NHI_Security_to_Cloud_NHIs__1.mp4

Logo – https://laotiantimes.com/wp-content/uploads/2025/04/silverfort_logo_new.jpg